In March 2025, the company declared new strategies for a immediate-to-client offering of its Wegovy weight loss drug. The company proven a brand new pharmacy, termed NovoCare, which might demand buyers $499 a month for access to the drug, a lot less than 50 % the price of the drug by way of other pharmaceutical distribution networks.[fifty three]As